Sonendo, Inc. (NYSE:SONX) CEO Bjarne Bergheim Acquires 11,748 Shares

Sonendo, Inc. (NYSE:SONXGet Rating) CEO Bjarne Bergheim purchased 11,748 shares of the company’s stock in a transaction on Wednesday, May 25th. The stock was purchased at an average price of $2.60 per share, for a total transaction of $30,544.80. Following the purchase, the chief executive officer now directly owns 921,097 shares of the company’s stock, valued at approximately $2,394,852.20. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

Bjarne Bergheim also recently made the following trade(s):

  • On Wednesday, May 18th, Bjarne Bergheim purchased 12,000 shares of Sonendo stock. The stock was purchased at an average price of $2.67 per share, for a total transaction of $32,040.00.
  • On Monday, May 16th, Bjarne Bergheim purchased 30,000 shares of Sonendo stock. The stock was purchased at an average price of $2.95 per share, for a total transaction of $88,500.00.
  • On Friday, May 13th, Bjarne Bergheim sold 4,101 shares of Sonendo stock. The shares were sold at an average price of $2.78, for a total transaction of $11,400.78.

Shares of NYSE:SONX opened at $2.71 on Thursday. Sonendo, Inc. has a 1-year low of $2.50 and a 1-year high of $12.24. The company has a debt-to-equity ratio of 0.46, a quick ratio of 6.02 and a current ratio of 6.86. The company has a 50 day moving average price of $3.41 and a 200 day moving average price of $5.80.

Sonendo (NYSE:SONXGet Rating) last issued its earnings results on Tuesday, May 10th. The company reported ($0.59) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.57) by ($0.02). Sell-side analysts predict that Sonendo, Inc. will post -2.24 earnings per share for the current year.

Several research analysts have recently issued reports on SONX shares. The Goldman Sachs Group decreased their price objective on shares of Sonendo from $30.00 to $10.00 and set a “buy” rating for the company in a report on Thursday, March 24th. Zacks Investment Research upgraded shares of Sonendo from a “sell” rating to a “hold” rating in a report on Wednesday. Morgan Stanley started coverage on shares of Sonendo in a report on Monday, January 31st. They issued an “equal weight” rating and a $6.90 price objective for the company. Finally, Piper Sandler decreased their price objective on shares of Sonendo from $12.00 to $7.00 in a report on Wednesday, May 11th. Two investment analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Buy” and a consensus target price of $10.32.

Several large investors have recently modified their holdings of SONX. Northern Trust Corp purchased a new stake in shares of Sonendo in the 4th quarter valued at approximately $76,000. Bank of America Corp DE purchased a new stake in shares of Sonendo in the 4th quarter valued at approximately $31,000. Skandinaviska Enskilda Banken AB publ purchased a new stake in shares of Sonendo in the 4th quarter valued at approximately $4,796,000. Ensign Peak Advisors Inc purchased a new stake in shares of Sonendo in the 4th quarter valued at approximately $958,000. Finally, General Atlantic L.P. purchased a new stake in shares of Sonendo in the 4th quarter valued at approximately $18,822,000. Institutional investors and hedge funds own 80.42% of the company’s stock.

Sonendo Company Profile (Get Rating)

Sonendo, Inc, a commercial-stage medical technology company, develops, manufactures, and commercializes devices for root canal therapy in the United States and Canada. It provides GentleWave, a tooth decay treatment device for cleaning and disinfecting the microscopic spaces within teeth without the need to remove tooth structure.

Recommended Stories

Insider Buying and Selling by Quarter for Sonendo (NYSE:SONX)

Receive News & Ratings for Sonendo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sonendo and related companies with MarketBeat.com's FREE daily email newsletter.